U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07034742) titled 'Exploratory Study on the Application of Molecular Residual Disease (MRD) in Postoperative Treatment of Gastric Cancer' on June 14.
Brief Summary: Gastric cancer is one of the most prevalent and lethal malignancies in China. The majority of patients are diagnosed at the locally advanced stage. Despite standard treatment involving radical resection combined with adjuvant chemotherapy, approximately 40% of patients experience recurrence and metastasis, with peritoneal metastasis accounting for nearly half of these cases.
Building upon our team's previous establishment of next-generation sequencing (NGS) technology for detecting molecu...